Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zevra Therapeutics Inc
Total Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Total Liabilities
$111.9m
CAGR 3-Years
140%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Liabilities
$108.1B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities
$76.5B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Total Liabilities
$128.5B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Total Liabilities
$73B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Total Liabilities
$61.4B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
14%

See Also

What is Zevra Therapeutics Inc's Total Liabilities?
Total Liabilities
111.9m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Total Liabilities amounts to 111.9m USD.

What is Zevra Therapeutics Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
3%

Over the last year, the Total Liabilities growth was 203%. The average annual Total Liabilities growth rates for Zevra Therapeutics Inc have been 140% over the past three years , 3% over the past five years .

Back to Top